Neuropace, Inc. NPCE Total investment securities
Total investment securities at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsFairValueDisclosure.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s total investment securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s total investment securities?
- Neuropace, Inc. (NPCE) reported total investment securities of $39.2M in Q1 2026.
- How has Neuropace, Inc.'s total investment securities changed year-over-year?
- Neuropace, Inc.'s total investment securities decreased by 0.1% year-over-year, from $39.24M to $39.2M.
- What is the long-term trend for Neuropace, Inc.'s total investment securities?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s total investment securities has grown at a 27.5% compound annual growth rate (CAGR), from $11.69M to $39.37M.
- What does total investment securities mean?
- Total portfolio of investment securities including AFS, HTM, and equity securities — a bank's primary non-loan earning asset.